325 related articles for article (PubMed ID: 21779178)
1. Molecular mechanisms generating and stabilizing terminal 22q13 deletions in 44 subjects with Phelan/McDermid syndrome.
Bonaglia MC; Giorda R; Beri S; De Agostini C; Novara F; Fichera M; Grillo L; Galesi O; Vetro A; Ciccone R; Bonati MT; Giglio S; Guerrini R; Osimani S; Marelli S; Zucca C; Grasso R; Borgatti R; Mani E; Motta C; Molteni M; Romano C; Greco D; Reitano S; Baroncini A; Lapi E; Cecconi A; Arrigo G; Patricelli MG; Pantaleoni C; D'Arrigo S; Riva D; Sciacca F; Dalla Bernardina B; Zoccante L; Darra F; Termine C; Maserati E; Bigoni S; Priolo E; Bottani A; Gimelli S; Bena F; Brusco A; di Gregorio E; Bagnasco I; Giussani U; Nitsch L; Politi P; Martinez-Frias ML; Martínez-Fernández ML; Martínez Guardia N; Bremer A; Anderlid BM; Zuffardi O
PLoS Genet; 2011 Jul; 7(7):e1002173. PubMed ID: 21779178
[TBL] [Abstract][Full Text] [Related]
2. Interstitial 22q13 deletions not involving SHANK3 gene: a new contiguous gene syndrome.
Disciglio V; Lo Rizzo C; Mencarelli MA; Mucciolo M; Marozza A; Di Marco C; Massarelli A; Canocchi V; Baldassarri M; Ndoni E; Frullanti E; Amabile S; Anderlid BM; Metcalfe K; Le Caignec C; David A; Fryer A; Boute O; Joris A; Greco D; Pecile V; Battini R; Novelli A; Fichera M; Romano C; Mari F; Renieri A
Am J Med Genet A; 2014 Jul; 164A(7):1666-76. PubMed ID: 24700646
[TBL] [Abstract][Full Text] [Related]
3. Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by
De Rubeis S; Siper PM; Durkin A; Weissman J; Muratet F; Halpern D; Trelles MDP; Frank Y; Lozano R; Wang AT; Holder JL; Betancur C; Buxbaum JD; Kolevzon A
Mol Autism; 2018; 9():31. PubMed ID: 29719671
[TBL] [Abstract][Full Text] [Related]
4. Chromothripsis and ring chromosome 22: a paradigm of genomic complexity in the Phelan-McDermid syndrome (22q13 deletion syndrome).
Kurtas N; Arrigoni F; Errichiello E; Zucca C; Maghini C; D'Angelo MG; Beri S; Giorda R; Bertuzzo S; Delledonne M; Xumerle L; Rossato M; Zuffardi O; Bonaglia MC
J Med Genet; 2018 Apr; 55(4):269-277. PubMed ID: 29378768
[TBL] [Abstract][Full Text] [Related]
5. A 29 Mainland Chinese cohort of patients with Phelan-McDermid syndrome: genotype-phenotype correlations and the role of SHANK3 haploinsufficiency in the important phenotypes.
Xu N; Lv H; Yang T; Du X; Sun Y; Xiao B; Fan Y; Luo X; Zhan Y; Wang L; Li F; Yu Y
Orphanet J Rare Dis; 2020 Nov; 15(1):335. PubMed ID: 33256793
[TBL] [Abstract][Full Text] [Related]
6. Phelan-McDermid syndrome: a classification system after 30 years of experience.
Phelan K; Boccuto L; Powell CM; Boeckers TM; van Ravenswaaij-Arts C; Rogers RC; Sala C; Verpelli C; Thurm A; Bennett WE; Winrow CJ; Garrison SR; Toro R; Bourgeron T
Orphanet J Rare Dis; 2022 Jan; 17(1):27. PubMed ID: 35093143
[TBL] [Abstract][Full Text] [Related]
7. A Brazilian cohort of individuals with Phelan-McDermid syndrome: genotype-phenotype correlation and identification of an atypical case.
Samogy-Costa CI; Varella-Branco E; Monfardini F; Ferraz H; Fock RA; Barbosa RHA; Pessoa ALS; Perez ABA; Lourenço N; Vibranovski M; Krepischi A; Rosenberg C; Passos-Bueno MR
J Neurodev Disord; 2019 Jul; 11(1):13. PubMed ID: 31319798
[TBL] [Abstract][Full Text] [Related]
8. A patient with the classic features of Phelan-McDermid syndrome and a high immunoglobulin E level caused by a cryptic interstitial 0.72-Mb deletion in the 22q13.2 region.
Simenson K; Õiglane-Shlik E; Teek R; Kuuse K; Õunap K
Am J Med Genet A; 2014 Mar; 164A(3):806-9. PubMed ID: 24375995
[TBL] [Abstract][Full Text] [Related]
9. Fraternal twins with Phelan-McDermid syndrome not involving the SHANK3 gene: case report and literature review.
Li S; Xi KW; Liu T; Zhang Y; Zhang M; Zeng LD; Li J
BMC Med Genomics; 2020 Oct; 13(1):146. PubMed ID: 33023580
[TBL] [Abstract][Full Text] [Related]
10. 22q13.2q13.32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan-McDermid syndrome.
Sarasua SM; Dwivedi A; Boccuto L; Chen CF; Sharp JL; Rollins JD; Collins JS; Rogers RC; Phelan K; DuPont BR
Genet Med; 2014 Apr; 16(4):318-28. PubMed ID: 24136618
[TBL] [Abstract][Full Text] [Related]
11. Clinical and genomic evaluation of 201 patients with Phelan-McDermid syndrome.
Sarasua SM; Boccuto L; Sharp JL; Dwivedi A; Chen CF; Rollins JD; Rogers RC; Phelan K; DuPont BR
Hum Genet; 2014 Jul; 133(7):847-59. PubMed ID: 24481935
[TBL] [Abstract][Full Text] [Related]
12. Clinical and genomic evaluation of a Chinese patient with a novel deletion associated with Phelan-McDermid syndrome.
Lei D; Li S; Banerjee S; Zhang H; Li C; Hou S; Chen D; Yan H; Li H; Peng HH; Liu S; Zhang X; Peng Z; Wang J; Yang H; Huang H; Wu J
Oncotarget; 2016 Dec; 7(49):80327-80335. PubMed ID: 27741506
[TBL] [Abstract][Full Text] [Related]
13. Position effects of 22q13 rearrangements on candidate genes in Phelan-McDermid syndrome.
Srikanth S; Jain L; Zepeda-Mendoza C; Cascio L; Jones K; Pauly R; DuPont B; Rogers C; Sarasua S; Phelan K; Morton C; Boccuto L
PLoS One; 2021; 16(7):e0253859. PubMed ID: 34228749
[TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype correlation in Phelan-McDermid syndrome: A comprehensive review of chromosome 22q13 deleted genes.
Ricciardello A; Tomaiuolo P; Persico AM
Am J Med Genet A; 2021 Jul; 185(7):2211-2233. PubMed ID: 33949759
[TBL] [Abstract][Full Text] [Related]
15. A translocation between Xq21.33 and 22q13.33 causes an intragenic SHANK3 deletion in a woman with Phelan-McDermid syndrome and hypergonadotropic hypogonadism.
Misceo D; Rødningen OK; Barøy T; Sorte H; Mellembakken JR; Strømme P; Fannemel M; Frengen E
Am J Med Genet A; 2011 Feb; 155A(2):403-8. PubMed ID: 21271662
[TBL] [Abstract][Full Text] [Related]
16. Functional genomics analysis of Phelan-McDermid syndrome 22q13 region during human neurodevelopment.
Ziats CA; Grosvenor LP; Sarasua SM; Thurm AE; Swedo SE; Mahfouz A; Rennert OM; Ziats MN
PLoS One; 2019; 14(3):e0213921. PubMed ID: 30875393
[TBL] [Abstract][Full Text] [Related]
17. Clinical characterization of novel chromosome 22q13 microdeletions.
Ha JF; Ahmad A; Lesperance MM
Int J Pediatr Otorhinolaryngol; 2017 Apr; 95():121-126. PubMed ID: 28576520
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms for subtelomeric rearrangements associated with the 9q34.3 microdeletion syndrome.
Yatsenko SA; Brundage EK; Roney EK; Cheung SW; Chinault AC; Lupski JR
Hum Mol Genet; 2009 Jun; 18(11):1924-36. PubMed ID: 19293338
[TBL] [Abstract][Full Text] [Related]
19. Definition and clinical variability of SHANK3-related Phelan-McDermid syndrome.
Schön M; Lapunzina P; Nevado J; Mattina T; Gunnarsson C; Hadzsiev K; Verpelli C; Bourgeron T; Jesse S; van Ravenswaaij-Arts CMA; ; Hennekam RC
Eur J Med Genet; 2023 Jul; 66(7):104754. PubMed ID: 37003575
[TBL] [Abstract][Full Text] [Related]
20. Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment.
Harony-Nicolas H; De Rubeis S; Kolevzon A; Buxbaum JD
J Child Neurol; 2015 Dec; 30(14):1861-70. PubMed ID: 26350728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
